Arnold C. Hanish - Feb 11, 2020 Form 4/A - Amendment Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Director
Signature
/s/David Arthur, as Attorney-in-Fact
Stock symbol
SLRX
Transactions as of
Feb 11, 2020
Transactions value $
$5,003
Form type
4/A - Amendment
Date filed
6/6/2022, 08:28 PM
Date Of Original Report
Feb 12, 2020
Previous filing
Jun 6, 2022
Next filing
Jun 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Purchase $5K +4.35K +145% $1.15 7.35K Feb 11, 2020 By Arnold C. Hanish Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on February 12, 2020 to reflect that the securities reported are indirectly beneficially owned as indicated herein.